education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Download App
Indonesia
search
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Country
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
search
UserName
Profession
Email
Account
Manage Account
Change Password
Sign Out
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
Others Services
Download App
Indonesia
China
Hong Kong
India
Indonesia
Malaysia
Myanmar
Philippines
Singapore
Thailand
Vietnam
Australia
Korea
New Zealand
More Services
education
|
UnregisterUser
|
IsNClickFreeLimitExceeded: True
|
NClickFreeLimit: 0
|
Manage Account
Sign in
Home
Find Drugs
Pill Identifier
Find Drug Company
Specialties
MIMS home
Drugs
Info
Vyepti
Vyepti
Manufacturer:
Lundbeck Export A/S
SELECT
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Bahasa Concise Prescribing Info
Full Prescribing Info
Contents
Indications/Uses
Dosage/Direction for Use
Overdosage
Contraindications
Special Precautions
Use In Pregnancy & Lactation
Adverse Reactions
Drug Interactions
MIMS Class
ATC Classification
Regulatory Classification
Presentation/Packing
Concise Prescribing Info
Contents
Eptinezumab
Indications/Uses
Prophylaxis of migraine in adults.
Click to view Vyepti detailed prescribing information
Dosage/Direction for Use
100 mg by IV infusion every 12 wk. May be administered as 300 mg by IV infusion every 12 wk.
Click to view Vyepti detailed prescribing information
Overdosage
View
Vyepti overdosage
for action to be taken in the event of an overdose.
Contraindications
Hypersensitivity.
Click to view Vyepti detailed prescribing information
Special Precautions
Discontinue if serious hypersensitivity reactions occur. Pregnancy & lactation.
Click to view Vyepti detailed prescribing information
Use In Pregnancy & Lactation
Click to view Vyepti detailed prescribing information
Adverse Reactions
Nasopharyngitis, hypersensitivity reactions.
Click to view Vyepti detailed prescribing information
MIMS Class
Antimigraine Preparations
ATC Classification
N02CD05 - eptinezumab ; Belongs to the class of calcitonin gene-related peptide (CGRP) antagonists preparations. Used to relieve migraine.
Regulatory Classification
G
Presentation/Packing
Form
Vyepti infusion conc 100 mg/mL
Packing/Price
1's
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Continue with Google
OR
Sign Up
Already a member?
Sign in